PBM - Psyence Biomedical Limited Debt to Book Capitalization Ratio

Psyence Biomedical Ltd. (PBM) occupies a narrow niche, developing psychedelic support methods for cancer patients. The company's total debt relative to book capitalization on the GURU.Markets base chart demonstrates financial stability, where 0.00 reflects the latest metric value. However, the asset is undergoing a deep restructuring to attract investment, facing regulatory barriers and the high volatility typical of early-stage biopharmaceutical development.

The market evaluates Psyence Biomedical Ltd. (PBM) through the lens of financial stability and environmental responsibility. This ratio compares total liabilities to total assets minus liabilities, determining the extent of the business's dependence on creditors. By analyzing the distribution of borrowed capital within the balance sheet capitalization, an investor can see the balance between default risk and growth rates. Compliance with ESG standards during metal extraction requires stable financing without excessive debt pressure. A low indicator value confirms the high autonomy and protection of the company's capital.